Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantification of regional calcium burden in chronic total occlusion by 64-slice multi-detector computed tomography and procedural outcomes of percutaneous coronary intervention.
Cho JR, Kim YJ, Ahn CM, Moon JY, Kim JS, Kim HS, Kim MK, Ko YG, Choi D, Chung N, Choe KO, Shim WH, Cho SY, Jang Y. Cho JR, et al. Among authors: kim yj, kim js, kim hs, kim mk. Int J Cardiol. 2010 Nov 5;145(1):9-14. doi: 10.1016/j.ijcard.2009.05.006. Epub 2009 Jun 11. Int J Cardiol. 2010. PMID: 19520444
Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial.
Ahn JM, Park DW, Kim YH, Song H, Cho YR, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Han S, Lee SY, Lee BK, Cho JH, Yang TH, Lee NH, Yang JY, Park JS, Shin WY, Kim MH, Bae JH, Kim MK, Yoon J, Park SJ. Ahn JM, et al. Among authors: kim yh, kim wj, kim mh, kim mk. Circ Cardiovasc Interv. 2012 Oct;5(5):633-40. doi: 10.1161/CIRCINTERVENTIONS.111.965673. Epub 2012 Oct 9. Circ Cardiovasc Interv. 2012. PMID: 23048051 Clinical Trial.
Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study.
Park DW, Kim YH, Song HG, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Her SH, Hur SH, Park JS, Kim MK, Choi YS, Kim HS, Cho JH, Lee SG, Park YW, Jeong MH, Lee BK, Lee NH, Lim DS, Yoon J, Seung KB, Shin WY, Rha SW, Kim KS, Tahk SJ, Park BE, Ahn T, Yang JY, Jeong YS, Rhew JH, Park SJ; IRIS-DES Investigators. Park DW, et al. Among authors: kim yh, kim wj, kim ks, kim hs, kim mk. Circ Cardiovasc Interv. 2012 Jun;5(3):365-71. doi: 10.1161/CIRCINTERVENTIONS.111.966549. Epub 2012 Jun 12. Circ Cardiovasc Interv. 2012. PMID: 22693347
BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial.
Yoon CH, Choi YJ, Park JJ, Kang SH, Kim SH, Suh JW, Cho YS, Youn TJ, Kim MK, Cha KS, Lee SH, Hong BK, Rha SW, Kang WC, Lee JH, Kim SH, Chae IH; Collaborators. Yoon CH, et al. Among authors: kim sh, kim mk. EuroIntervention. 2021 Apr 20;16(17):1404-1412. doi: 10.4244/EIJ-D-20-00185. EuroIntervention. 2021. PMID: 32958459 Free PMC article. Clinical Trial.
BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study.
Yoon CH, Kwun JS, Choi YJ, Park JJ, Kang SH, Kim SH, Suh JW, Youn TJ, Kim MK, Cha KS, Lee SH, Hong BK, Rha SW, Kang WC, Lee JH, Kim SH, Chae IH. Yoon CH, et al. Among authors: kim sh, kim mk. Circ Cardiovasc Interv. 2023 Jan;16(1):e012307. doi: 10.1161/CIRCINTERVENTIONS.122.012307. Epub 2022 Dec 7. Circ Cardiovasc Interv. 2023. PMID: 36475473 Clinical Trial.
4,402 results